<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using loss of heterozygosity (LOH) and X-chromosome inactivation, we compared peripheral blood (PB) plasma with bone marrow (BM) cells in detecting genomic abnormalities in patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We detected LOH in the PB plasma of <z:hpo ids='HP_0000001'>all</z:hpo> 45 patients who had cytogenetically documented chromosomal abnormalities (5q-, 7-, +8, 17-, or 20-) </plain></SENT>
<SENT sid="2" pm="."><plain>BM cells from the same patients showed LOH in 89% of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 70% of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Posttherapy samples from 16 of these patients demonstrated complete concordance between LOH and cytogenetics in detecting <z:e sem="disease" ids="C0543478" disease_type="Neoplastic Process" abbrv="">residual disease</z:e> in 15 samples </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 16 samples, 4 showed LOH in plasma with <z:mpath ids='MPATH_458'>normal</z:mpath> BM <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Using X-chromosome inactivation, clonality was detectable in 19 (73%) of 26 BM samples, whereas <z:hpo ids='HP_0000001'>all</z:hpo> PB plasma samples showed clonality </plain></SENT>
<SENT sid="6" pm="."><plain>These data support the conclusion that PB plasma is enriched by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific DNA and can replace BM cells for studying genomic abnormalities </plain></SENT>
</text></document>